Form 4 for ZBH Zimmer Biomet
Accepted 2025-02-24 00:00:00 ET · period of report 2025-02-20 · accession 0001062993-25-003332 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-02-24 | 2025-02-20 | ZBH | Yi Sang | Group Pres, Asia Pacific | M - OptEx | $0.00 | +2,383 | 19.1K | +14% | $0 |
| D | 2025-02-24 | 2025-02-20 | ZBH | Yi Sang | Group Pres, Asia Pacific | M - OptEx | $0.00 | -2,383 | 4,764 | -33% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-20 | M | A | 2,383 | $0.00 | 19,059 | D | — | — | |
| 2 | Derivative | Restricted Stock Units | 2025-02-20 | M | D | 2,383 | $0.00 | 4,764 | D | — · — to — | 2,383 Common Stock | (F1) Each RSU represents a contingent right to receive one share of Company common stock. (F2) One-third of the RSUs vested on February 20, 2025. The remaining RSUs vest one-half on each of February 20, 2026 and February 20, 2027. |